These findings align with clinical observations that TP53 (tumor protein p53 gene) mutations are associated with higher histopathological grades in astrocytoma and are prevalent in early gastric lesions, alongside elevated SASP (cGAS–STING) and DDR markers [49]. The gene discussed is TP53; the disease is astrocytoma (excluding glioblastoma).